This article is more than 5 years old. Information may no longer be current.

Guardion Health Sciences completes Series B funding

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

Guardion Health Sciences announced it has completed a Series B funding round with $3.1 million raised, according to a company press release.

The money is to be used in accelerating expansion of the company’s operations, implementing its sales and marketing strategy, and completing development of products in its pipeline, the release said.

Guardion Health Sciences formulates and distributes medical foods, specifically those that address depleted macular protective pigment.